Search results

Articles (5)

Journals (0)

1-5 of 5 results for capsid assembly modulator

Sort by:

Relevance

Select all

Sort by:

Relevance

Free accessResearch articleFirst published January, 2021

Pharmacokinetics,safety and tolerability of single- and multiple-ascending doses of JNJ-64530440,a novel hepatitis B virus capsid assembly modulator,in healthy volunteers

Thomas N Kakuda, Jeysen Z Yogaratnam, Christopher Westland [...]

Antiviral Therapy

Open accessResearch articleFirst published December, 2025

A Phase 1 study of the safety,tolerability,and pharmacokinetics of ALG-000184 (pevifoscorvir sodium),a novel Class E capsid assembly modulator,in healthy participants

Ed Gane, Christian Schwabe, Min Wu [...]

Antiviral Therapy

Open accessResearch articleFirst published December, 2022

EDP-514 in healthy subjects and nucleos(t)ide reverse transcriptase inhibitor-suppressed patients with chronic hepatitis B

Jordan J Feld, Eric Lawitz, Tuan Nguyen [...]

Antiviral Therapy

Open accessReview articleFirst published 2020

Advances in hepatitis B therapeutics

Vicente Soriano, Pablo Barreiro, Edward Cachay [...]

Therapeutic Advances in Infectious Disease

Open accessResearch articleFirst published June, 2022

JNJ-73763989 pharmacokinetics and safety: Liver-targeted siRNAs against hepatitis B virus,in Japanese and non-Japanese healthy adults,and combined with JNJ-56136379 and a nucleos(t)ide analogue in patients with chronic hepatitis B

Ed Gane, Man-Fung Yuen, Thomas N Kakuda [...]

Antiviral Therapy

Search results

Articles (5)

Journals (0)

1-5 of 5 results for capsid assembly modulator

Sort by:

Relevance

Select all

Sort by:

Relevance

Free accessResearch articleFirst published January, 2021

Pharmacokinetics,safety and tolerability of single- and multiple-ascending doses of JNJ-64530440,a novel hepatitis B virus capsid assembly modulator,in healthy volunteers

Thomas N Kakuda, Jeysen Z Yogaratnam, Christopher Westland [...]

Antiviral Therapy

Open accessResearch articleFirst published December, 2025

A Phase 1 study of the safety,tolerability,and pharmacokinetics of ALG-000184 (pevifoscorvir sodium),a novel Class E capsid assembly modulator,in healthy participants

Ed Gane, Christian Schwabe, Min Wu [...]

Antiviral Therapy

Open accessResearch articleFirst published December, 2022

EDP-514 in healthy subjects and nucleos(t)ide reverse transcriptase inhibitor-suppressed patients with chronic hepatitis B

Jordan J Feld, Eric Lawitz, Tuan Nguyen [...]

Antiviral Therapy

Open accessReview articleFirst published 2020

Advances in hepatitis B therapeutics

Vicente Soriano, Pablo Barreiro, Edward Cachay [...]

Therapeutic Advances in Infectious Disease

Open accessResearch articleFirst published June, 2022

JNJ-73763989 pharmacokinetics and safety: Liver-targeted siRNAs against hepatitis B virus,in Japanese and non-Japanese healthy adults,and combined with JNJ-56136379 and a nucleos(t)ide analogue in patients with chronic hepatitis B

Ed Gane, Man-Fung Yuen, Thomas N Kakuda [...]

Antiviral Therapy